Potassium-Competitive Acid Blockers versus Proton Pump Inhibitors for Healing of Erosive Esophagitis: A Systematic Review and Meta-Analysis
Bali Medical and Wellness Journal · 16.08.2026 · 3 (2)
DOI: 10.71341/bmwj.v3i2.59 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Bali Medical and Wellness Journal, online erschienen am 16.08.2026. Verfasst von Gede Made Cahya Trisna Pratama und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Background
Erosive esophagitis (EE) is a prevalent manifestation of gastroesophageal reflux disease that requires potent acid suppression for mucosal recovery. While proton pump inhibitors (PPIs) are the standard therapy, their efficacy is often limited by slow onset and genetic polymorphisms. Potassium-competitive acid blockers (P-CABs) have emerged as a novel alternative with superior pharmacokinetic properties.
Objective
This systematic review and meta-analysis aimed to evaluate the comparative efficacy and safety of P-CABs versus PPIs in achieving mucosal healing and symptom relief in patients with EE.
Methods
Following PRISMA 2020 guidelines, a systematic search was conducted across major databases for randomized controlled trials (RCTs) published through 2025. Nine RCTs involving 2,927 participants were included. Data on healing rates at weeks 4 and 8, heartburn disappearance, serum gastrin levels, and adverse events were synthesized using fixed and random-effects models.
Results
P-CABs demonstrated significant superiority in mucosal healing compared to PPIs at week 4 (OR: 1.47; 95% CI: 1.09–2.00; p=0.01) and week 8 (OR: 2.04; 95% CI: 1.41–2.95; p=0.0002). P-CABs also achieved faster heartburn disappearance (MD: -1.29 days; p=0.01). Although P-CABs resulted in higher serum gastrin levels (MD: 121.74 pg/mL; p=0.0007), safety profiles were comparable between groups with no significant differences in adverse events.
Conclusion
P-CABs provide faster and more effective mucosal healing than PPIs with a comparable safety profile, representing a robust breakthrough for the management of erosive esophagitis.
Zitieren
APA
Pratama, G. M. C. T., & Nugraha, K. A. W. (2026). Potassium-Competitive Acid Blockers versus Proton Pump Inhibitors for Healing of Erosive Esophagitis: A Systematic Review and Meta-Analysis. Bali Medical and Wellness Journal, 3(2). https://doi.org/10.71341/bmwj.v3i2.59
Vancouver
Pratama GMCT, Nugraha KAW. Potassium-Competitive Acid Blockers versus Proton Pump Inhibitors for Healing of Erosive Esophagitis: A Systematic Review and Meta-Analysis. Bali Medical and Wellness Journal. 2026;3(2). doi:10.71341/bmwj.v3i2.59
BibTeX
@article{Pratama2026,
author = {Pratama, Gede Made Cahya Trisna and Nugraha, Komang Agus Wira},
title = {Potassium-Competitive Acid Blockers versus Proton Pump Inhibitors for Healing of Erosive Esophagitis: A Systematic Review and Meta-Analysis},
journal = {Bali Medical and Wellness Journal},
year = {2026},
volume = {3},
number = {2},
doi = {10.71341/bmwj.v3i2.59}
}
EUVIMED